A new trading day began on Friday, with Ginkgo Bioworks Holdings Inc (NYSE: DNA) stock price up 4.11% from the previous day of trading, before settling in for the closing price of $12.17. DNA’s price has ranged from $5.00 to $16.85 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -27.97% over the past five years. Meanwhile, its annual earnings per share averaged 50.15%. With a float of $40.51 million, this company’s outstanding shares have now reached $43.82 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ginkgo Bioworks Holdings Inc is 27.92%, while institutional ownership is 58.35%. The most recent insider transaction that took place on Aug 22 ’25, was worth 3,843. In this transaction an insider of this company sold 310 shares at a rate of $12.40, taking the stock ownership to the 11,112 shares. Before that another transaction happened on Aug 06 ’25, when Company’s Officer proposed sale 2,200 for $14.10, making the entire transaction worth $31,020.
Ginkgo Bioworks Holdings Inc (DNA) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.08 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.27 per share during the current fiscal year.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Trading Performance Indicators
Here are Ginkgo Bioworks Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.85, a number that is poised to hit -1.24 in the next quarter and is forecasted to reach -4.35 in one year’s time.
Technical Analysis of Ginkgo Bioworks Holdings Inc (DNA)
Ginkgo Bioworks Holdings Inc (NYSE: DNA) saw its 5-day average volume 1.65 million, a positive change from its year-to-date volume of 1.54 million. As of the previous 9 days, the stock’s Stochastic %D was 48.22%.
During the past 100 days, Ginkgo Bioworks Holdings Inc’s (DNA) raw stochastic average was set at 71.64%, which indicates a significant increase from 52.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.07 in the past 14 days, which was higher than the 0.84 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.85, while its 200-day Moving Average is $9.66. Nevertheless, the first resistance level for the watch stands at $13.20 in the near term. At $13.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.39. If the price goes on to break the first support level at $12.02, it is likely to go to the next support level at $11.37. The third support level lies at $10.83 if the price breaches the second support level.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Key Stats
With a market capitalization of 750.06 million, the company has a total of 59,200K Shares Outstanding. Currently, annual sales are 227,040 K while annual income is -547,030 K. The company’s previous quarter sales were 49,600 K while its latest quarter income was -60,300 K.
